Department of Pediatrics, University of South Florida, Tampa, FL, USA.
J Med Syst. 2010 Aug;34(4):651-7. doi: 10.1007/s10916-009-9278-5. Epub 2009 Apr 3.
The National Institutes of Health has proposed a roadmap for clinical research. Test projects of this roadmap include centralized data management for distributed research, the harmonization of clinical and research data, and the use of data standards throughout the research process. In 2003, RxNorm was named as a standard for codifying clinical drugs. Clinical researchers looking to implement RxNorm have few template implementation plans. Epidemiological studies and clinical trials (types of clinical research) have different requirements for model standards and best implementation tools. This paper highlights two different (epidemiological and intervention) clinical research projects, their unique requirements for a medication standard, the suitability of RxNorm as a standard for each, and application and process requirements for implementation. It is hoped that our experience of selecting and implementing the RxNorm standard to address varying study requirements in both domestic and international settings will be of value to other efforts.
美国国立卫生研究院提出了临床研究的路线图。该路线图的测试项目包括分布式研究的集中数据管理、临床和研究数据的协调,以及在整个研究过程中使用数据标准。2003 年,RxNorm 被命名为临床药物编码的标准。希望实施 RxNorm 的临床研究人员很少有模板实施计划。开展流行病学研究和临床试验(临床研究的两种类型)对模型标准和最佳实施工具的要求不同。本文重点介绍了两个不同的(流行病学和干预)临床研究项目,它们对药物标准的独特要求,RxNorm 作为各自标准的适用性,以及实施的应用和流程要求。希望我们在国内外环境中选择和实施 RxNorm 标准来满足不同研究要求的经验,对其他工作有借鉴价值。